Abstract
Articular cartilage defects are a common problem in joints. As articular cartilage has a limited intrinsic capability for self-repair, their clinical treatment remains problematic as none of the current therapeutic options can regenerate adult cartilage and prevent the development of osteoarthritis (OA) over the long term. Treatments based on therapeutic gene vectors typically involve approaches based on the intraarticular delivery of gene vectors or of genetically modified cells, sometimes via biocompatible materials. This review highlights the current state of gene therapy strategies for cartilage repair.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
